Lung cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Subjects voluntarily join this study, sign the informed consent form, and cooperate with the follow-up; 2. Lung cancer diagnosed by histology/cytology at the Lung Cancer Center of West China Hospital, Sichuan University (according to AJCC 9th edition); 3. Age>=18 years old, male or female; 4. Plan to receive anti-tumor therapy and be able to provide informed consent; 5. The MDT group has undergone at least one MDT discussion; 6. Estimated survival >=3 months; 7. The subjects had good compliance and cooperated with follow-up.
Exclusion criteria
Exclusion criteria: 1. Combined with other tumors; 2. Those who have a history of psychotropic drug abuse and cannot be quit or have mental disorders; 3. As judged by the investigator, the subject has other factors that may lead to the forced termination of the study, such as other serious diseases (including mental illnesses) that require concurrent treatment, serious abnormal laboratory test values, family or social factors, and it is difficult to follow up for a long time; 4. Other conditions judged by the investigator to be unsuitable for inclusion in this study (only receiving palliative treatment, etc.).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 2-year overall survival rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of Life Score;Patient Satisfaction Evaluation;1-year survival;5-year survival;Median Progression-Free Survival;Incidence of Treatment-Emergent Adverse Events; | — |
Countries
China
Contacts
West China Hospital, Sichuan University